Home › Narcolepsy › Georgia › Atlanta
Narcolepsy clinical trials in Atlanta, GA
5 studies for Narcolepsy are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- Atlanta, Georgia, Atlanta
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
RecruitingPhase 3
- Neurotrials Research Inc, Atlanta
- Clinical Research Institute Stockbridge, Stockbridge · 17 mi away
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2/3
- Alkermes Investigational Site, Atlanta
- Alkermes Investigational Site, Stockbridge · 17 mi away
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
RecruitingPhase 2
- NeuroTrials Research, Inc, Atlanta
- Clinical Research Institute Stockbridge, Stockbridge · 17 mi away
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
RecruitingPhase 2
- Stockbridge, GA, Atlanta
- Atlanta, Georgia, Atlanta
Narcolepsy trials in other cities
- Miami, FL7 studies
- Cincinnati, OH7 studies
- Columbia, SC6 studies
- Austin, TX6 studies
- Charlotte, NC6 studies
- Orlando, FL5 studies
- San Antonio, TX5 studies
- Sugar Land, TX4 studies
- Macon, GA4 studies
- Los Angeles, CA4 studies
- Brandon, FL4 studies
- Columbus, OH4 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Acute Myeloid Leukemia30 studies
- Lung Cancer29 studies
- Colorectal Cancer29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Obesity25 studies
- Major Depressive Disorder25 studies
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.